"Schizophrenic Psychology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Study of mental processes and behavior of schizophrenics.
| Descriptor ID |
D012565
|
| MeSH Number(s) |
F04.824
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenic Psychology".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenic Psychology".
This graph shows the total number of publications written about "Schizophrenic Psychology" by people in this website by year, and whether "Schizophrenic Psychology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 2 | 4 |
| 1995 | 6 | 3 | 9 |
| 1996 | 6 | 3 | 9 |
| 1997 | 6 | 2 | 8 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 3 | 4 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 3 | 0 | 3 |
| 2011 | 3 | 0 | 3 |
| 2012 | 7 | 2 | 9 |
| 2013 | 2 | 0 | 2 |
| 2014 | 6 | 1 | 7 |
| 2015 | 5 | 0 | 5 |
| 2016 | 4 | 1 | 5 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schizophrenic Psychology" by people in Profiles.
-
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia. JAMA Psychiatry. 2022 02 01; 79(2):169-177.
-
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial. Schizophr Res. 2019 09; 211:103-104.
-
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial. Schizophr Res. 2019 04; 206:325-332.
-
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
-
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017 12 01; 174(12):1195-1202.
-
?9-tetrahydrocannabinol (?9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacol Biochem Behav. 2017 08; 159:6-11.
-
Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
-
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2017 Mar 01; 174(3):216-229.
-
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model. Biol Psychiatry. 2017 03 15; 81(6):503-513.
-
Differential profiles in auditory social cognition deficits between adults with autism and schizophrenia spectrum disorders: A preliminary analysis. J Psychiatr Res. 2016 08; 79:21-27.